STOCKHOLDERS' EQUITY | NOTE 6. STOCKHOLDERS' EQUITY Common Stock The Company issued the following shares of common stock for the years ended December 31, 2023 and 2022: During the year ended December 31, 2023, the Company issued 1,906,100 200,196 During the year ended December 31, 2023, the Company issued 1,800,000 300,000 During the year ended December 31, 2022, the Company converted its loan principal of $ 1,459,489 20,250 1,479,739 20,000,000 520,261 In September 2022, the Company issued 75,000 75,000 In July and August 2022, the Company issued 10,000,000 1,000,000 During the period from June through December 31, 2022, the Company issued 1,400,000 140,000 In May 2022, the Company issued 75,000 shares of common stock valued at $1.00 per share for $ 225,000 225,000 In May 2022, the Company issued 100,000 100,000 In May 2022, the Company issued 1,000,000 1,000,000 333,333 In April 2022, the Company issued 730,000 1,041,200 4,010 Stock Based Compensation During 2021 the Company adopted the 2021 Equity Incentive Plan (the “Plan”) the total number of shares of common stock authorized under Plan totals 10,000,000 6,941,000 In addition to awards granted from the Plan, the Company has granted equity and equity-linked awards for various employees and non-employees at the discretion of the Compensation Committee of the Board of Directors. The fair value of the awards estimated at the grant date are earned and recognized over the requisite service period. Warrants During the year ended December 31, 2023 the Company issued 102,470 0.01 104,502 The grant date fair value of the warrants not previously recognized totaled $ 26,694 The Company estimated the fair value of the warrants on the grant date using a Black-Scholes options pricing model using the quoted market price on the grant date; exercise price of $0.01 per share; expected volatility of approximately 80%; the contractual term of two years; and the risk-free interest rate of 0.2%. A summary of the common stock warrant activity is as follows: Schedule of warrant activity Warrants Weighted Weighted Outstanding at January 1, 2023 – $ – – Warrants granted 102,470 0.01 Exercised – – Forfeited, cancelled or expired – – Outstanding at December 31, 2023 102,470 $ 0.01 1.75 Exercisable at December 31, 2023 102,470 $ 0.01 1.75 Stock Appreciation Rights During the year ended December 31, 2023 the Company issued 5,296,099 1,860,000 The Company estimated the fair value of the SARs on the grant date using a Black-Scholes options pricing model using the quoted market price on the grant date; exercise prices ranging from $0.29 to $0.50 per share; expected volatility of approximately 80%; the contractual term of seven years; and a risk-free interest rate of 3.0%. A summary of the stock appreciation rights activity is as follows: Schedule of stock appreciation rights activity Stock Weighted Weighted Outstanding at January 1, 2023 – $ – – Granted 5,296,099 0.41 Exercised – – Forfeited, cancelled or expired – – Outstanding at December 31, 2023 5,296,099 $ 0.41 6.78 Exercisable at December 31, 2023 1,758,000 $ 0.44 6.78 The grant date fair value of the stock appreciation rights issued during the twelve months ended December 31, 2023 totaled $ 1,567,186 Included in the stock appreciation rights granted during the year ended December 31, 2023; 28,000 15,726 93,983 78,527 During the twelve months ended December 31, 2023 the Company recognized total expense associated with the SARs totaling $ 1,152,010 415,177 As of December 31, 2023, the Company has committed 3,058,505 |